Histone Deacetylase 4: The Epigenetic Hub in Degenerative Musculoskeletal Diseases

Read full text Summarise with VIRAT
Authors: Junyan Huang, Zhengming Wang, Guoqing Du, Zhaozhou Zhang, Mingcai Zhang, Yuanyuan Feng, Yayi Tan, Hong Zhao, Shanshan Zhang, Yizhe Xiong, Xing Wang, Junwei Shen
+1 more Hongsheng Zhan
Cited by: 0
References: 93

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Aging has rendered Degenerative Musculoskeletal Diseases (DMDs) an increasingly significant public health burden. Growing evidence suggests that epigenetic dysregulation plays a crucial mechanistic role in the pathogenesis of DMDs. Histone Deacetylase 4 (HDAC4), known for its regulatory roles in the nervous, cardiovascular, and cancer systems, has also emerged as a central coordinator of musculoskeletal physiology and pathology. It dynamically modulates cellular metabolism in cartilage, bone, and muscle tissues. This review aims to provide a comprehensive overview of current research on HDAC4 in the context of DMDs, highlighting its roles in chondrocyte homeostasis, synovial inflammation, osteoblast-osteoclast balance, and muscle fiber atrophy. Furthermore, we explore the therapeutic potential of targeting HDAC4 for the treatment of musculoskeletal diseases, including osteoarthritis, osteoporosis, and muscle atrophy.

Fields of Study & Subjects

Osteoarthritis Treatment and Mechanisms Histone Deacetylase Inhibitors Research Bone Metabolism and Diseases

Publication details

Journal / source
Endocrine Metabolic & Immune Disorders - Drug Targets
Volume
26
Pages
e18715303416616–e18715303416616
Publication date
30 March 2026
Language
EN